Clinical Trial Update: ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation [NA]

View source ↗

Summary

The clinical trial evaluating ABCB5 as a prognostic marker in survival after cultivated limbal stem cell transplantation for limbal stem cell deficiency has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limbal Stem Cell Deficiency

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Limbal Stem Cell Deficiency | NA | Status: TERMINATED